by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials
The SRC has granted unanimous approval for TransCode to open the fourth cohort in its Phase I trial of TTX-MC138. The SRC has granted unanimous approval for TransCode to open the fourth cohort in its Phase I trial of TTX-MC138.
by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials
Vir Biotechnology has enrolled the first subject in the Phase III ECLIPSE registrational programme of tobevibart plus elebsiran. Vir Biotechnology has enrolled the first subject in the Phase III ECLIPSE registrational programme of tobevibart plus...
by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials
The study, involving 35,000 participants, aims to assess the vaccine’s effectiveness, and if successful, it could be included in the universal healthcare system The study, involving 35,000 participants, aims to assess the vaccine’s effectiveness, and if...
by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials
Knowing exactly what to do when a protocol deviation (PD) arises can be challenging. Here, consultant Leila Cupersmith summarizes new FDA guidance on managing PDs. Knowing exactly what to do when a protocol deviation (PD) arises can be challenging. Here,...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint No anti-drug… Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Researchers from Liverpool School of Tropical Medicine (LSTM) have completed a Phase I clinical trial for a new oral treatment for snakebite. Researchers from Liverpool School of Tropical Medicine (LSTM) have completed a Phase I clinical trial for a new oral...
